 |
| Global Benzodiazepine Drugs Market Size |
Benzodiazepines
are a class of psychoactive drugs used in the treatment of anxiety disorders,
insomnia, seizures, and more. They work to enhance the effect of the
neurotransmitter gamma-aminobutyric acid (GABA) in the brain.
The global
benzodiazepine drugs market is estimated to be valued at US$ 3148.01 Mn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The increased prescription of benzodiazepines for the treatment of anxiety and
insomnia has been one of the major trends driving the growth of the
benzodiazepine drugs market. Benzodiazepines have demonstrated efficacy in
relieving anxiety and aiding sleep and are therefore commonly prescribed
medications for these conditions. Moreover, the prevalence of anxiety and
insomnia has been on the rise globally due to high stress levels and changing
lifestyle patterns. This has resulted in increasing demand for anxiolytic and
hypnotic drugs like benzodiazepines. The market is expected to witness
significant gains over the forecast period supported by rising prescription
rates of benzodiazepines for anxiety and insomnia.
Segment
Analysis
The global Benzodiazepine Drugs market is dominated by the anti-anxiety sub
segment, which holds around 50% share of the overall market. This is because
benzodiazepines are widely prescribed for the treatment of anxiety disorders
due to their rapid onset of action and effectiveness in alleviating anxiety
symptoms. The anti-anxiety sub segment is followed by the sedative-hypnotic sub
segment which accounts for approximately 30% share.
Key Takeaways
Global
Benzodiazepine Drugs Market Size is expected to witness high growth
over the forecast period owing to the increasing prevalence of anxiety &
sleep disorders.
Regional Analysis: Asia Pacific region dominates the global Benzodiazepine
Drugs market and is expected to maintain its leading position during the
forecast period. This is attributed to factors such as rising geriatric
population, growing awareness regarding anxiety disorders & availability of
generic drugs at low costs in Asia Pacific countries. China represents the
fastest growing market for Benzodiazepine Drugs in the Asia Pacific region.
Key players: Key players operating in the Benzodiazepine Drugs market are
Bioderma Laboratories, Lotus Herbals Pvt. Ltd., Natura & Co., Kao
Corporation, Beiersdorf AG, Procter & Gamble Co., Unilever PLC, Moroccan
Oil, L'Oreal SA, Himalaya Wellness Company, Johnson & Johnson Inc., and The
Estee Lauder Companies Inc. The Estee Lauder Companies Inc. is one of the
leading players in the global skincare market and offers a wide range of
Benzodiazepine Drugs under its brands such as Estee Lauder, Clinique, Origins
etc.
Explore
More Related Article On This Topic: https://www.pressreleasebulletin.com/benzodiazepine-drugs-market-size/
https://www.shayaricenter.com/artificial-kidney-a-solution-to-end-stage-kidney-disease